Clinical Trial Update: Clinical Trial Evaluating the Safety and Efficacy of Moxidectin 2 mg Ivermectin-controlled in Loa Loa Microfilaremic Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of moxidectin 2 mg in Loa loa microfilaremic patients with an ivermectin-controlled design; the study status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Loiasis
• Onchocerciasis

Drugs mentioned

• IVERMECTIN (Ivermectin)
• Moxidectin (moxidectin)

Snippet

Sponsor: Center for Research on Filariasis and Other Tropical Diseases, Cameroon | Conditions: Onchocerciasis, Ocular, Loiasis | Phase 2 | Status: COMPLETED